Trial intelligence / Profile preview

Dopamine and Reward Learning Across Hormonal Transition Phases

NCT06365515Recruiting

Sponsor
University Hospital Tübingen
Start
May 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of levodopa (3 arms), sponsored by University Hospital Tübingen. Primary endpoints: Motivation to work for rewards: force of pressing grip force device, Reward-related brain responses in the reward network and 2 more. Started May 2024; status: recruiting.

02

Drugs

levodopa

Beyond the preview

Go deeper on NCT06365515.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06365515.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call